Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury

MS Al-Naimi, HA Rasheed, NR Hussien… - Journal of advanced …, 2019 - journals.lww.com
Nephrotoxicity is defining as rapid deterioration in the kidney function due to toxic effect of
medications and chemicals. There are various forms, and some drugs may affect renal …

[HTML][HTML] Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis

X Yang, H Yan, X Zhang, X Qin, P Guo - International Journal of Infectious …, 2022 - Elsevier
Objectives Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are recommended as
first-line treatments for chronic hepatitis B (CHB). However, the safety of these two drugs …

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection

YM Yang, EJ Choi - Therapeutics and clinical risk management, 2017 - Taylor & Francis
Background Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are recommended as
the first-line therapy for chronic hepatitis B (CHB) due to their genetic barrier to resistance …

Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study

YE Chon, SY Park, SU Kim, HP Hong… - Journal of Viral …, 2022 - Wiley Online Library
Renal safety is a critical issue in chronic hepatitis B (CHB) patients receiving long‐term
entecavir (ETV) or tenofovir disofuroxil fumarate (TDF) therapy. We investigated their effects …

[HTML][HTML] Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis

HY Lee, H Oh, CH Park, YH Yeo… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Recently, the American Association for the Study of Liver Disease
suggested no preference between tenofovir (TDF) and entecavir (ETV) regarding potential …

[PDF][PDF] Renal function in patients with chronic hepatitis B during antiviral therapy.

N Čustović, L Alić, I Rašić, A Saray, A Mehmedović… - Medicinski …, 2024 - ljkzedo.ba
Aim To analyse the impact of the length of antiviral therapy with tenofovir disoproxil fumarate
(TDF) on the renal function in patients with chronic hepatitis B (CHB). Methods A cross …

Pathway association studies reveal gene loci and pathway networks that associated with plasma cystatin C levels

H Jiao, M Zhang, Y Zhang, Y Wang, WD Li - Frontiers in Genetics, 2021 - frontiersin.org
As a marker for glomerular filtration, plasma cystatin C level is used to evaluate kidney
function. To decipher genetic factors that control the plasma cystatin C level, we performed …

Is urinary β2-microglobulin a reliable marker for assessment of renal tubular dysfunction in chronic hepatitis B patients receiving tenofovir therapy?

M Atef, N Zayed, R Salama, SA Alem… - European Journal of …, 2021 - journals.lww.com
Methods Forty-two HBV patients who were a candidate for TDF therapy or have recently
started it (for less than 6 months) were enrolled and subjected to demographic, clinical …

[引用][C] Colistin Nephrotoxicity in The Critically Ill Patient

KYH Soler, JMP Corbacho, SSS Salcedo… - 2023 - biomedscis.com
Background: The kidney is a major drug excretion organ and is therefore exposed to high
concentrations of potentially toxic drugs. Nephrotoxicity is defined as a rapid deterioration of …

[PDF][PDF] WJG

SM Lee, HW Lee, KS Lee - World J Gastroenterol, 2019 - pdfs.semanticscholar.org
Hepatocellular carcinoma (HCC) is one of major causes of cancer mortality worldwide. For
decades, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has been …